Longitudinal study of specific IgE and IgG antibodies in a patient sensitized to ethylene oxide through dialysis.
IgE and IgG antibodies to ethylene oxide (EO) were monitored by RAST and by ELISA in serum from a patient with hypersensitivity reactions during hemodialysis. Serum samples from the patient covering a 7-year period were analyzed. The changes in titers of IgE and IgG antibodies correlated to the time of EO exposure as well as to clinical symptoms. EO-specific IgG antibodies were, however, also found in sera from hemodialysis patients without any hypersensitivity symptoms. Assay of specific IgG antibodies will only indicate whether a patient has been exposed to, and immunostimulated by, EO, whereas specific IgE antibodies appear to be clearly related to hypersensitivity symptoms. The hapten and carrier specificity of EO-induced IgE antibodies was studied. The antibodies were found to be solely hapten specific because carriers of different types could be used in RAST without changing the outcome of the test. The existence of new antigenic determinants related to the carrier could not be demonstrated.
Wass
U
U
Asthma and Allergy Research Center, Department of Medicine I, Sahlgrenska Hospital, Göteborg, Sweden.
Belin
L
L
Delin
K
K
D000328:Adult; D004797:Enzyme-Linked Immunosorbent Assay; D005027:Ethylene Oxide / Q000276:immunology*; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007073:Immunoglobulin E / Q000276:immunology*; D007074:Immunoglobulin G / Q000276:immunology*; D008297:Male; D011852:Radioallergosorbent Test; D006435:Renal Dialysis / Q000009:adverse effects*; D013997:Time Factors
D007074:Immunoglobulin G; D007073:Immunoglobulin E; D005027:Ethylene Oxide